Year |
Citation |
Score |
2020 |
Tayob N, Corley DA, Christie I, Almers L, Rahal AK, Richardson P, White DL, Davila J, Kanwal F, El-Serag HB. Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-based Cohort of Patients With Cirrhosis of Multiple Etiologies. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 32768590 DOI: 10.1016/J.Cgh.2020.07.065 |
0.391 |
|
2020 |
Choi DT, Davila JA, Sansgiry S, David E, Singh H, El-Serag HB, Hsiao-Fan Sada Y. Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients with Cirrhosis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 32693047 DOI: 10.1016/J.Cgh.2020.07.026 |
0.42 |
|
2020 |
Wilson Dib R, Dandachi D, Matar M, Shayya A, Davila JA, Giordano TP, Mokhbat JE. HIV in Lebanon: Reasons for Testing, Engagement in Care, and Outcomes in Patients with Newly Diagnosed HIV Infections. Aids and Behavior. PMID 31965431 DOI: 10.1007/S10461-020-02788-3 |
0.316 |
|
2018 |
Tayob N, Christie I, Richardson P, Feng Z, White DL, Davila J, Corley DA, Kanwal F, El-Serag HB. Validation of the Hepatocellular Carcinoma Early detection Screening (HES) algorithm in a Cohort of Veterans with Cirrhosis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 30557738 DOI: 10.1016/J.Cgh.2018.12.005 |
0.431 |
|
2018 |
Zou WY, El-Serag HB, Sada YH, Temple SL, Sansgiry S, Kanwal F, Davila JA. Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Digestive Diseases and Sciences. PMID 29508165 DOI: 10.1007/S10620-018-4989-4 |
0.435 |
|
2018 |
Tayob N, Richardson P, White DL, Yu X, Davila JA, Kanwal F, Feng Z, El-Serag HB. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. Bmc Medical Research Methodology. 18: 1. PMID 29301497 DOI: 10.1186/S12874-017-0458-6 |
0.433 |
|
2018 |
Zou WY, Temple S, Sada YH, El-Serag HB, May SB, Kanwal F, Richardson P, Anaya DA, Davila J. Tu1489 - Improved Treatment Delivery and Overall Survival Associated with Multidisciplinary Tumor Board Evaluation of Patients with Advanced Hepatocellular Carcinoma Gastroenterology. 154: S-1236. DOI: 10.1016/S0016-5085(18)34067-8 |
0.376 |
|
2017 |
Akce M, Sansgiry S, Temple SL, Davila J, Sada Y. The effect of treatment delay on survival in patients with hepatocellular cancer. Journal of Clinical Oncology. 35: e15645-e15645. DOI: 10.1200/Jco.2017.35.15_Suppl.E15645 |
0.382 |
|
2017 |
Temple S, Sada YH, El-Serag H, Mittal S, Kanwal F, Anaya DA, Davila J. Utilizing a Multidisciplinary Tumor Board for the Management of Hepatocellular Carcinoma is Associated with Improved Outcomes Gastroenterology. 152: S1192. DOI: 10.1016/S0016-5085(17)33975-6 |
0.345 |
|
2017 |
Tayob N, Richardson P, Kanwal F, White D, Yu X, Zou WY, Castillo D, Davila J, El-Serag H. Performance of AFP-Based Hepatocellular Carcinoma Surveillance in Cirrhosis Patients with Cured HCV Gastroenterology. 152: S1077-S1078. DOI: 10.1016/S0016-5085(17)33634-X |
0.37 |
|
2017 |
Tayob N, Richardson P, Kanwal F, White D, Yu X, Davila J, El-Serag H. Evaluation of Screening Approaches for Hepatocellular Carcinoma in Cirrhosis Patients from the Veteran's Affairs Health Care System Gastroenterology. 152: S1042. DOI: 10.1016/S0016-5085(17)33528-X |
0.372 |
|
2016 |
White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of Hepatocellular Carcinoma in all 50 United States, From 2000 Through 2012. Gastroenterology. PMID 27889576 DOI: 10.1053/J.Gastro.2016.11.020 |
0.427 |
|
2016 |
Khalaf N, Ying J, Mittal S, Temple S, Kanwal F, Davila J, El-Serag HB. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 27521507 DOI: 10.1016/J.Cgh.2016.07.033 |
0.454 |
|
2016 |
Mittal S, Kanwal F, Ying J, Chung R, Sada YH, Temple S, Davila JA, El-Serag HB. Effectiveness of Surveillance for Hepatocellular Carcinoma in Clinical Practice: A United States cohort. Journal of Hepatology. PMID 27476765 DOI: 10.1016/J.Jhep.2016.07.025 |
0.441 |
|
2016 |
Walker M, El-Serag HB, Sada Y, Mittal S, Ying J, Duan Z, Richardson P, Davila JA, Kanwal F. Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer. Alimentary Pharmacology & Therapeutics. PMID 26784271 DOI: 10.1111/Apt.13505 |
0.41 |
|
2016 |
Khalaf N, Ying J, Mittal S, Temple S, Kanwal F, Davila J, El-Serag HB. Mo1494 Natural History of Untreated HCC in a U.S. Cohort and the Role of Cancer Surveillance Gastroenterology. 150: S1130. DOI: 10.1016/S0016-5085(16)33816-1 |
0.382 |
|
2015 |
White DL, Richardson P, Tayoub N, Davila JA, Kanwal F, El-Serag HB. The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis. Gastroenterology. 149: 1986-7. PMID 26519622 DOI: 10.1053/J.Gastro.2015.10.004 |
0.342 |
|
2015 |
Massarweh NN, Davila JA, El-Serag HB, Duan Z, Temple S, May S, Sada YH, Anaya DA. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard. The Journal of Surgical Research. PMID 26507276 DOI: 10.1016/J.Jss.2015.09.034 |
0.411 |
|
2015 |
Mittal S, El-Serag HB, Sada YH, Kanwal F, Duan Z, Temple S, May SB, Kramer JR, Richardson PA, Davila JA. Hepatocellular Carcinoma in the Absence of Cirrhosis in US Veterans is Associated with Non-Alcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 26196445 DOI: 10.1016/J.Cgh.2015.07.019 |
0.413 |
|
2015 |
Flash CA, Pasalar S, Hemmige V, Davila JA, Hallmark CJ, McNeese M, Miertschin N, Ruggerio MC, Giordano TP. Benefits of a routine opt-out HIV testing and linkage to care program for previously diagnosed patients in publicly funded emergency departments in Houston, TX. Journal of Acquired Immune Deficiency Syndromes (1999). 69: S8-15. PMID 25867782 DOI: 10.1097/Qai.0000000000000578 |
0.31 |
|
2015 |
Mittal S, Sada YH, El-Serag HB, Kanwal F, Duan Z, Temple S, May SB, Kramer JR, Richardson PA, Davila JA. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 13: 594-601.e1. PMID 25148760 DOI: 10.1016/J.Cgh.2014.08.013 |
0.424 |
|
2015 |
Kanwal F, Walker M, Sada YH, Mittal S, Duan Z, El-Serag HB, Davila J. Sa1870 Cirrhosis Is Underrecognized in Patients Subsequently Diagnosed With HCC Gastroenterology. 148: S-1030. DOI: 10.1016/S0016-5085(15)33522-8 |
0.417 |
|
2014 |
Salami AC, Barden GM, Castillo DL, Hanna M, Petersen NJ, Davila JA, Naik AD, Anaya DA. Establishment of a Regional Virtual Tumor Board Program to Improve the Process of Care for Patients With Hepatocellular Carcinoma. Journal of Oncology Practice / American Society of Clinical Oncology. PMID 25466708 DOI: 10.1200/Jop.2014.000679 |
0.399 |
|
2014 |
El-Serag HB, Kanwal F, Davila JA, Kramer J, Richardson P. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. Gastroenterology. 146: 1249-55.e1. PMID 24462733 DOI: 10.1053/J.Gastro.2014.01.045 |
0.411 |
|
2014 |
Davila JA, Sada YH, Kanwal F, Mittal S, Hartman CM, Temple S, May SB, El-Serag H. Tu1005 Outcomes Associated With Co-Utilization of VA and Medicare Healthcare Benefits in Patients With Hepatocellular Carcinoma Gastroenterology. 146: S-1003-S-1004. DOI: 10.1016/S0016-5085(14)63650-7 |
0.4 |
|
2014 |
Mittal S, Sada Y, El-Serag H, Duan Z, Temple S, May SB, Kramer JR, Richardson P, Davila JA. Mo1035 Surveillance and Outcomes in Non-Alcoholic Fatty Liver Disease Related Hepatocellular Carcinoma in Veteran Affairs (VA) Population Gastroenterology. 146: S-991-S-992. DOI: 10.1016/S0016-5085(14)63604-0 |
0.348 |
|
2014 |
Sada Y, David E, Hartman CM, Sada DM, Chang E, El-Serag H, Davila JA. Sa1001 Quality of Diagnostic Processes for Hepatocellular Cancer in United States Veterans Gastroenterology. 146: S-933. DOI: 10.1016/S0016-5085(14)63392-8 |
0.344 |
|
2014 |
Mittal S, Sada Y, El-Serag H, Kanwal F, Duan Z, Temple S, May SB, Kramer JR, Richardson P, Davila JA. 637 Temporal Trends of Non-Alcoholic Fatty Liver Disease Related Hepatocellular Carcinoma in Veteran Affairs (VA) Population Gastroenterology. 146: S-917. DOI: 10.1016/S0016-5085(14)63333-3 |
0.343 |
|
2014 |
El-Serag H, Mittal S, Kanwal F, Duan Z, Sada Y, Temple S, May SB, Davila JA. 636 HCC in the Absence of Cirrhosis in United States Veterans: an Emerging Disease Entity Associated With Features of Metabolic Syndrome Gastroenterology. 146: S-917. DOI: 10.1016/S0016-5085(14)63332-1 |
0.418 |
|
2014 |
El-Serag H, Kanwal F, Davila JA, Kramer JR, Richardson P. Mo1275 A New Lab Based Algorithm for HCC Surveillance in Patients With Cirrhosis Gastroenterology. 146: S-605. DOI: 10.1016/S0016-5085(14)62190-9 |
0.397 |
|
2013 |
David E, El-Serag H, Singh H, Davila J. Guideline adherence for diagnosis of liver cancer in veterans. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 89. PMID 28136504 DOI: 10.1200/Jco.2013.31.31_Suppl.89 |
0.411 |
|
2013 |
Sada Y, Hou J, Richardson P, El-Serag H, Davila J. Validation of Case Finding Algorithms for Hepatocellular Cancer From Administrative Data and Electronic Health Records Using Natural Language Processing. Medical Care. PMID 23929403 DOI: 10.1097/Mlr.0B013E3182A30373 |
0.388 |
|
2013 |
El-Serag HB, Alsarraj A, Richardson P, Davila JA, Kramer JR, Durfee J, Kanwal F. Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey. Digestive Diseases and Sciences. 58: 3117-26. PMID 23868438 DOI: 10.1007/S10620-013-2794-7 |
0.4 |
|
2013 |
Welzel TM, Graubard BI, Quraishi S, Zeuzem S, Davila JA, El-Serag HB, McGlynn KA. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. The American Journal of Gastroenterology. 108: 1314-21. PMID 23752878 DOI: 10.1038/Ajg.2013.160 |
0.389 |
|
2013 |
Davila JA, Kramer JR, Duan Z, Richardson PA, Tyson GL, Sada YH, Kanwal F, El-Serag HB. Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology (Baltimore, Md.). 57: 1858-68. PMID 23359313 DOI: 10.1002/Hep.26287 |
0.451 |
|
2013 |
Jafri NS, Gould M, El-Serag HB, Duan Z, Davila JA. Incidence and survival of colorectal cancer among Hispanics in the United States: a population-based study. Digestive Diseases and Sciences. 58: 2052-60. PMID 23086126 DOI: 10.1007/S10620-012-2454-3 |
0.315 |
|
2013 |
Davila JA, Sada YH, Kramer JR, Duan Z, Richardson P, El-Serag H. Tu1033 Treatment and Outcomes of Hepatocellular Carcinoma in Patients With Idiopathic Disease Gastroenterology. 144: S-1036-S-1037. DOI: 10.1016/S0016-5085(13)63854-8 |
0.377 |
|
2013 |
Richardson P, Kanwal F, Davila JA, Kramer JR, Zhigang D, El-Serag H. Tu1030 The Adjusted AFP Algorithm Improves the Predictive Value for HCC During Surveillance Gastroenterology. 144: S-1036. DOI: 10.1016/S0016-5085(13)63851-2 |
0.344 |
|
2012 |
Davila JA, Duan Z, McGlynn KA, El-Serag HB. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. Journal of Clinical Gastroenterology. 46: 71-7. PMID 22157221 DOI: 10.1097/Mcg.0B013E318224D669 |
0.435 |
|
2012 |
Richardson P, Duan Z, Kramer J, Davila JA, Tyson GL, El-Serag HB. Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 10: 428-33. PMID 22155556 DOI: 10.1016/J.Cgh.2011.11.025 |
0.379 |
|
2012 |
Davila JA, El-Serag H. 458 The Rising Incidence of Hepatocellular Carcinoma in the United States: an Update Gastroenterology. 142: S-914. DOI: 10.1016/S0016-5085(12)63549-5 |
0.409 |
|
2011 |
Tyson GL, Duan Z, Kramer JR, Davila JA, Richardson PA, El-Serag HB. Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 9: 989-94. PMID 21820396 DOI: 10.1016/J.Cgh.2011.07.026 |
0.424 |
|
2011 |
Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (Baltimore, Md.). 54: 463-71. PMID 21538440 DOI: 10.1002/Hep.24397 |
0.409 |
|
2011 |
El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how? Therapeutic Advances in Gastroenterology. 4: 5-10. PMID 21317990 DOI: 10.1177/1756283X10385964 |
0.435 |
|
2011 |
El-Serag HB, Kramer JR, Chen GJ, Duan Z, Richardson PA, Davila JA. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut. 60: 992-7. PMID 21257990 DOI: 10.1136/Gut.2010.230508 |
0.409 |
|
2011 |
Davila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z, El-Serag HB. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Annals of Internal Medicine. 154: 85-93. PMID 21242365 DOI: 10.7326/0003-4819-154-2-201101180-00006 |
0.429 |
|
2011 |
Davila JA, El-Serag HB. Surveillance for Hepatocellular Carcinoma Annals of Internal Medicine. 155: 275. DOI: 10.7326/0003-4819-155-4-201108160-00019 |
0.397 |
|
2011 |
Welzel TM, Graubard BI, Davila JA, El-Serag HB, McGlynn KA. Abstract 945: Metabolic syndrome increases the risk of primary liver cancer in the United States Cancer Research. 71: 945-945. DOI: 10.1158/1538-7445.Am2011-945 |
0.419 |
|
2011 |
Davila JA, Kramer JR, Richardson PA, Duan Z, El-Serag H. Referral and Treatment of Hepatocellular Carcinoma in United States Veterans Gastroenterology. 140: S-935. DOI: 10.1016/S0016-5085(11)63876-6 |
0.396 |
|
2011 |
Tyson GL, Kramer JR, Davila JA, Duan Z, Richardson PA, El-Serag H. Alpha-Fetoprotein Levels Are Predictive of Survival in Hepatitis C-Related Hepatocellular Carcinoma in a United States Veterans Cohort Gastroenterology. 140: S-913-S-914. DOI: 10.1016/S0016-5085(11)63790-6 |
0.376 |
|
2011 |
Kramer JR, Davila JA, Duan Z, Richardson PA, Kanwal F, El-Serag H. Antiviral Treatment for Hepatitis C Virus is Associated With a Reduced Risk of Hepatocellular Carcinoma in a National Cohort of U.S. Veterans Gastroenterology. 140: S-899. DOI: 10.1016/S0016-5085(11)63730-X |
0.358 |
|
2011 |
Jafri N, Gould M, El-Serag H, Davila JA. Colorectal Cancer in Hispanics: A Population-Based Study of Trends in Incidence and Survival Gastroenterology. 140: S-345-S-346. DOI: 10.1016/S0016-5085(11)61405-4 |
0.3 |
|
2010 |
Richardson P, Henderson L, Davila JA, Kramer JR, Fitton CP, Chen GJ, El-Serag HB. Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data. Digestive Diseases and Sciences. 55: 3241-51. PMID 20844957 DOI: 10.1007/S10620-010-1387-Y |
0.388 |
|
2010 |
Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (Baltimore, Md.). 52: 132-41. PMID 20578139 DOI: 10.1002/Hep.23615 |
0.445 |
|
2010 |
Davila JA. Diabetes and hepatocellular carcinoma: what role does diabetes have in the presence of other known risk factors? The American Journal of Gastroenterology. 105: 632-4. PMID 20203644 DOI: 10.1038/Ajg.2009.715 |
0.369 |
|
2010 |
McGlynn KA, Quraishi S, Welzel TM, Davila JA, El-Serag HB, Graubard BI. Abstract 1816: Attributable risks for hepatocellular carcinoma in the United States Cancer Research. 70: 1816-1816. DOI: 10.1158/1538-7445.Am10-1816 |
0.35 |
|
2010 |
Davila JA, Duan Z, McGlynn KA, El-Serag H. T1002 Utilization and Outcomes of Palliative Therapy for Hepatocellular Carcinoma: A Population-Based Study in the United States Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)63841-3 |
0.372 |
|
2010 |
El-Serag H, Henderson L, Kramer JR, Richardson P, Kanwal F, Davila JA. T1000 Utilization of Surveillance for Hepatocellular Carcinoma Among HCV Infected Patients in the United States Gastroenterology. 138: S-833. DOI: 10.1016/S0016-5085(10)63839-5 |
0.361 |
|
2009 |
El-Serag HB, Henderson L, Kramer JR, Kanwal F, Richardson P, Davila JA. W1773 State of Treatment for Hepatocellular Carcinoma in Patients with HCV Infection in the Department of Veterans Affairs Gastroenterology. 136: A-858-A-859. DOI: 10.1016/S0016-5085(09)63959-7 |
0.364 |
|
2009 |
Davila JA, Richardson P, Morgan RO, Du XL, McGlynn KA, El-Serag HB. 739 Outcomes of Screening for Hepatocellular Carcinoma in the United States Gastroenterology. 136: A-804. DOI: 10.1016/S0016-5085(09)63711-2 |
0.384 |
|
2008 |
Davila JA, Morgan R, Du XL, Richardson P, McGlynn KA, El-Serag HB. 782 Utilization of Screening for Hepatocellular Carcinoma in the United States Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)63593-3 |
0.388 |
|
2007 |
Shaib YH, Davila JA, Henderson L, McGlynn KA, El-Serag HB. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study. Journal of Clinical Gastroenterology. 41: 911-7. PMID 18090160 DOI: 10.1097/Mcg.0B013E31802F3132 |
0.313 |
|
2007 |
El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Archives of Internal Medicine. 167: 1983-9. PMID 17923599 DOI: 10.1001/Archinte.167.18.1983 |
0.395 |
|
2007 |
Davila JA, Weston A, Smalley W, El-Serag HB. Utilization of screening for hepatocellular carcinoma in the United States. Journal of Clinical Gastroenterology. 41: 777-82. PMID 17700427 DOI: 10.1097/Mcg.0B013E3180381560 |
0.418 |
|
2007 |
Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 5: 1221-8. PMID 17689296 DOI: 10.1016/J.Cgh.2007.05.020 |
0.326 |
|
2007 |
Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus ML. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer. 110: 660-9. PMID 17582625 DOI: 10.1002/Cncr.22826 |
0.319 |
|
2007 |
Shaib Y, Davila J, Naumann C, El-Serag H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. The American Journal of Gastroenterology. 102: 1377-82. PMID 17403071 DOI: 10.1111/J.1572-0241.2007.01202.X |
0.316 |
|
2006 |
Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 4: 104-10; quiz 4-5. PMID 16431312 DOI: 10.1016/S1542-3565(05)00745-7 |
0.43 |
|
2006 |
El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. Journal of Hepatology. 44: 158-66. PMID 16290309 DOI: 10.1016/J.Jhep.2005.10.002 |
0.43 |
|
2005 |
Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 54: 533-9. PMID 15753540 DOI: 10.1136/Gut.2004.052167 |
0.407 |
|
2004 |
Davila JA, Brooks JM, Pendergast JF, Chrischilles EA. The effect of physician characteristics and their practice environment on surgical referral patterns for early-stage breast cancer in Iowa. American Journal of Medical Quality : the Official Journal of the American College of Medical Quality. 19: 266-73. PMID 15620078 DOI: 10.1177/106286060401900606 |
0.493 |
|
2004 |
Rabeneck L, Davila JA, Thompson M, El-Serag HB. Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system. Alimentary Pharmacology & Therapeutics. 20: 1115-24. PMID 15569114 DOI: 10.1111/J.1365-2036.2004.02215.X |
0.318 |
|
2004 |
Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 127: 1372-80. PMID 15521006 DOI: 10.1053/J.Gastro.2004.07.020 |
0.441 |
|
2004 |
Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? Journal of Hepatology. 40: 472-7. PMID 15123362 DOI: 10.1016/J.Jhep.2003.11.030 |
0.301 |
|
2004 |
Rabeneck L, Davila JA, Thompson M, El-Serag HB. Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. The American Journal of Gastroenterology. 99: 668-75. PMID 15089900 DOI: 10.1111/J.1572-0241.2004.04135.X |
0.305 |
|
2004 |
El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology (Baltimore, Md.). 39: 798-803. PMID 14999699 DOI: 10.1002/Hep.20096 |
0.44 |
|
2003 |
El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Annals of Internal Medicine. 139: 817-23. PMID 14623619 DOI: 10.7326/0003-4819-139-10-200311180-00009 |
0.409 |
|
2003 |
Davila JA, Petersena NJ, Nelson HA, El-Serag HB. Geographic variation within the United States in the incidence of hepatocellular carcinoma. Journal of Clinical Epidemiology. 56: 487-93. PMID 12812824 DOI: 10.1016/S0895-4356(02)00605-4 |
0.404 |
|
2003 |
El-Serag HB, Davila J, Petersen N. The incidence of hepatocellular carcinoma in the united states; Is it still rising? Gastroenterology. 124: A690. DOI: 10.1016/S0016-5085(03)83490-X |
0.408 |
|
2002 |
Davila JA, El-Serag HB. Cholangiocarcinoma: the "other" liver cancer on the rise. The American Journal of Gastroenterology. 97: 3199-200. PMID 12492212 DOI: 10.1111/J.1572-0241.2002.07132.X |
0.324 |
|
2002 |
Davila J, Petersen N, El-Serag H. #5 Birth cohort effect and the incidence of hepatocellular carcinoma Annals of Epidemiology. 12: 491. DOI: 10.1016/S1047-2797(02)00293-4 |
0.361 |
|
2002 |
Davila J, Petersen N, Nelson H, El-Serag H. #4 Using hierarchial linear modeling to examine geographic variation in hepatocellular carcinoma Annals of Epidemiology. 12: 491. DOI: 10.1016/S1047-2797(02)00292-2 |
0.395 |
|
Show low-probability matches. |